Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZCCHC18 Inhibitors

ZCCHC18, also known as Zinc Finger CCHC-Type Containing 18, is a protein that plays a significant role in the regulation of RNA metabolism and processing within the cellular environment. This protein is characterized by its zinc finger domains, which are typically involved in binding to RNA or DNA and modulating various aspects of nucleic acid metabolism, including splicing, transcription, and translation. ZCCHC18 has been implicated in the fine-tuning of gene expression at the post-transcriptional level, contributing to the regulation of mRNA stability and translation efficiency. These functions are critical for cellular adaptation to environmental changes and for the maintenance of cellular homeostasis. Moreover, ZCCHC18's role extends to the regulation of non-coding RNAs, underscoring its importance in a wide array of cellular processes, from growth and proliferation to differentiation and apoptosis.

The inhibition of ZCCHC18 can occur through several mechanisms that impact its function in RNA metabolism. One primary method of inhibition is the direct interaction with regulatory proteins that modulate its activity or stability. Proteins that interact with ZCCHC18 can alter its ability to bind RNA, thereby inhibiting its regulatory functions. Additionally, post-translational modifications such as phosphorylation, methylation, or ubiquitination can modify the structural integrity or localization of ZCCHC18, affecting its efficiency and capacity to perform its roles within the RNA processing machinery. Another significant aspect of ZCCHC18 inhibition involves genetic regulation; alterations in the expression levels of ZCCHC18 through transcriptional repression or RNA interference can lead to a decrease in its functional protein levels, thereby diminishing its influence on RNA metabolism. These mechanisms collectively ensure that the activity of ZCCHC18 is finely controlled, allowing cells to adjust the expression of various genes in response to developmental cues and external stressors effectively.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3K inhibitor that can inhibit downstream pathways potentially involving ZCCHC18.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 also targets the PI3K pathway, thus affecting cellular processes that may require ZCCHC18 involvement.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Known for its broad kinase inhibitory properties, Staurosporine may affect kinase-dependent pathways that ZCCHC18 operates in.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

A Src family kinase inhibitor; ZCCHC18 could be indirectly affected if it's a part of Src-related signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an ERK pathway inhibitor and can affect the protein if it's involved in ERK-mediated cellular processes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor that may affect ZCCHC18's function if it's associated with JNK pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

This p38 MAPK inhibitor may have an impact if ZCCHC18 operates in a p38 MAPK-dependent pathway.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

As a proteasome inhibitor, MG132 can indirectly affect ZCCHC18 by modulating its degradation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Targets the mTOR pathway, which could be linked to cellular processes involving ZCCHC18.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

As a PP1 and PP2A inhibitor, it may affect ZCCHC18 if it's involved in phosphatase-dependent pathways.